NS
Narin Sehgal
About Narin Sehgal
Data last updated:
Narin Sehgal is a Director at Sehgal Minimal Access Surgery Training Institute (Smasti) Private Limited (since 2024). Sehgal Minimal Access Surgery Training Institute (Smasti) Private Limited reported revenue of ₹8.9 Lakh (FY 2025). Earlier, Narin Sehgal was a Director at My Pharma Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jun 2024 | 2024 | ₹8.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jun 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narin Sehgal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mridu Jain Sehgal | 10681593 | Sehgal Minimal Access Surgery Training Institute (Smasti) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narin Sehgal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narin Sehgal
Narin Sehgal currently holds 1 directorship: Sehgal Minimal Access Surgery Training Institute (Smasti) Private Limited (Director, since 25 Jun 2024, revenue ₹8.9 Lakh (FY 2025)).
Narin Sehgal was first appointed on 14 Jun 2012 as Director at My Pharma Private Limited. The most recent appointment on record is 25 Jun 2024 at Sehgal Minimal Access Surgery Training Institute (Smasti) Private Limited.
Narin Sehgal held 1 earlier board appointment: My Pharma Private Limited (Director, from 14 Jun 2012).
The current boards of Narin Sehgal's companies include Mridu Jain Sehgal (Sehgal Minimal Access Surgery Training Institute (Smasti) Private Limited).